<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0300">
 <label>59</label>
 <element-citation publication-type="journal" id="rf0290">
  <person-group person-group-type="author">
   <name>
    <surname>August</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Kpamegan</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hickman</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Jani</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age</article-title>
  <source>Vaccine</source>
  <volume>35</volume>
  <issue>30</issue>
  <year>2017</year>
  <fpage>3749</fpage>
  <lpage>3759</lpage>
  <ext-link ext-link-type="uri" xlink:href="pmid:28579233" id="ir0375" xmlns:xlink="http://www.w3.org/1999/xlink">28579233</ext-link>
  <pub-id pub-id-type="pmid">28579233</pub-id>
 </element-citation>
</ref>
